Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Leo James

Has grant

MRC Laboratory of Molecular Biology

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Biochemistry Biochemistry professors in United Kingdom

Recent Grants

Grant: Open

Targeted Pathogen Degradation and its Synergy with Antiviral Immunity

Open Date: 2027-06-17

Close Date: 2035-06-16

Grant: Open

'Trim-Away': Targeted Degradation of Proteins & Pathogens

Open Date: 2022-01-01

Close Date: 2026-12-31

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (19)

Maria Gabriella Santoro

PROFESSOR OF VIROLOGY

Università degli Studi di Roma La Sapienza

ITALY

View details

Taxiarchis Katsinelos

Assistant Professor

Aristotle University of Thessaloniki

GREECE

View details

Guido Papa

Ricercatori

University of Milan

ITALY

View details

Brenda Schulman

Director

Max Planck Institute of Biochemistry

GERMANY

View details

Silvia Pauciullo

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

ITALY

View details

John T. Vaage

Professor II

University of Oslo

NORWAY

View details

Denis E Kainov

Norwegian University of Science and Technology (NTNU)

NORWAY

View details

Even Fossum

Senior Researcher

Norwegian Institute of Public Health

NORWAY

View details

Till Böcking

Professor

University of New South Wales

AUSTRALIA

View details

William A. McEwan

University of Cambridge

UNITED KINGDOM

View details

Liuhong Chen

UNITED KINGDOM

View details

Leo Kiss

Junior Professor (tenure-track) of Cellular Biochemistry

Universität Duisburg-Essen

GERMANY

View details

David Jacques

Scientia Associate Professor

University of New South Wales

AUSTRALIA

View details

Maximilian Anthony James Harman

UNITED KINGDOM

View details

Jan Terje Andersen

Group leader

University of Oslo

NORWAY

View details

Michaela Rumlova

Head of Molecular Biology lab

Vysoká škola chemicko-technologická v Praze Fakulta chemické technologie

CZECH REPUBLIC

View details

James Stewart

Professor

University of Liverpool

UNITED KINGDOM

View details

James Walsh

UNSW Sydney

AUSTRALIA

View details

David France

Lecturer

University of Glasgow

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Leo James

Research Interests

Explore related searches

Recent Grants

Articles (20)

Mechanistic insights into lenacapavir-induced off-pathway HIV-1 capsid assembly

Retroviruses use different IP6 binding mechanisms to alter the properties of their capsids

TRIM21 Neutralizes Hazara Virus Using a Dual Mechanism of Nucleoprotein Caging and Ubiquitination

The host protein cyclophilin A restricts nuclear entry of HIV-1 mutants by reducing the elasticity of the viral capsid.

An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models.

State-selective small molecule degraders that preferentially remove aggregates and oligomers

UbiREAD deciphers proteasomal degradation code of homotypic and branched K48 and K63 ubiquitin chains

Author Correction: HIV-1 is dependent on its immature lattice to recruit IP6 for mature capsid assembly

How HIV-1 Uses the Metabolite Inositol Hexakisphosphate to Build Its Capsid.

Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure

Human coronaviruses activate and hijack the host transcription factor HSF1 to enhance viral replication

Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function

Aggregate-selective removal of pathological tau by clustering-activated degraders

Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21.

HIV-1 adapts to lost IP6 coordination through second-site mutations that restore conical capsid assembly

Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2

A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery

The type‐I interferon response potentiates seeded tau aggregation and exacerbates tau pathology

A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation.

The Effect of Inositol Hexakisphosphate on HIV-1 Particle Production and Infectivity can be Modulated by Mutations that Affect the Stability of the Immature Gag Lattice.

Collaborators (19)

Maria Gabriella Santoro

Taxiarchis Katsinelos

Guido Papa

Brenda Schulman

Silvia Pauciullo

John T. Vaage

Denis E Kainov

Even Fossum

Till Böcking

William A. McEwan

Liuhong Chen

Leo Kiss

David Jacques

Maximilian Anthony James Harman

Jan Terje Andersen

Michaela Rumlova

James Stewart

James Walsh

David France

Make your next move.